TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

24.70$ +1.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BEAM
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +6,853.0% -6.5% +189.4% +226.4% -9.0% +8.8% -24.4% +34.2%
– +7,179.1% -36.2% +226.1% +312.9% -14.1% +10.8% -27.5% +44.5%
– +7,603.5% -74.6% +335.7% +245.3% -58.4% +87.3% -35.3% +4.6%
– +7,603.5% -37.3% +226.3% +222.2% +11.6% +10.4% -28.5% +46.4%
– – – – – -100.0% – – –
– – – – – – – – –
– – +155.2% +189.9% +49.1% +25.2% – – –
– +400.9% +67.2% +273.7% +214.2% -6.1% -21.3% -22.6% -34.4%
– +289.7% +13.9% +251.2% +108.6% +4.8% -8.1% -11.4% -46.8%
– – – +12.3% +55.1% +5.6% +23.1% +5.4% +6.6%
– +912.5% +6.7% -19.5% +18.4% +20.8% -82.1% +139.4% +164.3%
– – – +20.0% -43.2% – – – –
– – -24.7% +143.3% +236.7% -11.3% +33.8% -25.2% +68.8%
– – – – – – – – –
– +171.3% +46.1% -9.0% +37.4% +9.0% +10.2% +6.7% +20.2%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?